{"nctId":"NCT00000479","briefTitle":"Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer","startDateStruct":{"date":"1992-09"},"conditions":["Cardiovascular Diseases","Cerebrovascular Disorders","Coronary Disease","Heart Diseases","Myocardial Infarction","Myocardial Ischemia","Vascular Diseases"],"count":39876,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Aspirin","Drug: Vitamin E"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Vitamin E","Behavioral: Placebo"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: Aspirin","Behavioral: Placebo"]},{"label":"4","type":"PLACEBO_COMPARATOR","interventionNames":["Behavioral: Placebo"]}],"interventions":[{"name":"Aspirin","otherNames":[]},{"name":"Vitamin E","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy women\n* No previous history of cardiovascular disease or cancer\n* No contraindications to aspirin or vitamin E","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"45 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Major Cardiovascular Events (a Combined Endpoint of Nonfatal Myocardial Infarction, Nonfatal Stroke, and Total Cardiovascular Death)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"245","spread":null},{"groupId":"OG001","value":"250","spread":null},{"groupId":"OG002","value":"232","spread":null},{"groupId":"OG003","value":"272","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"133","spread":null},{"groupId":"OG002","value":"108","spread":null},{"groupId":"OG003","value":"133","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96","spread":null},{"groupId":"OG001","value":"94","spread":null},{"groupId":"OG002","value":"102","spread":null},{"groupId":"OG003","value":"99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"52","spread":null},{"groupId":"OG002","value":"54","spread":null},{"groupId":"OG003","value":"74","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Cancer, Excluding Nonmelanoma Skin Cancer","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"722","spread":null},{"groupId":"OG001","value":"721","spread":null},{"groupId":"OG002","value":"716","spread":null},{"groupId":"OG003","value":"706","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"156","spread":null},{"groupId":"OG002","value":"152","spread":null},{"groupId":"OG003","value":"143","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":27,"n":9968},"commonTop":["report of GI upset","easy bruising","epistaxis","hematuria"]}}}